Month: June 2016

Visit BUHLMANN Diagnostics Corp at AACC 2016

When: July 31 - August 4, 2016 Where: Philadelphia, PA Booth: #4202 Learn More: AACC 2016

BÜHLMANN GanglioCombi™ MAG ELISA Utilized in Guillain-Barré Syndrome (GBS) and Zika Virus Study

The BÜHLMANN GanglioCombi™ MAG ELISA was recently utilized in a case-control study in French Polynesia focusing on individuals diagnosed with Guillain-Barré Syndrome (GBS). See publication below: Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study Learn More BÜHLMANN GanglioCombi® MAG ELISA is for Research Use Only. Not for use in diagnostic procedures in

Connect with BUHLMANN Diagnostics Corp at MGCC 2016!

When: June 18 - 22, 2016 Where: Edmonton, AB Canada Booth: #307 More Information: Joint Conference of the Canadian College of Medical Geneticists and the Canadian Society of Clinical Chemists (MGCC 2016)

BÜHLMANN Laboratories AG (BL), based in Basel Switzerland, has been discovering, developing & manufacturing innovative chemistry and immunological in-vitro diagnostic (IVD) and research use only (RUO) assays for almost 50 years (circa 1976). As the United States commercial affiliate of BL, BUHLMANN Diagnostics Corp (BDC), based in Amherst, NH is committed to providing exceptional sales, support, and technical services to our clinical, discovery and basic science research laboratory customers.

Month: June 2016

Visit BUHLMANN Diagnostics Corp at AACC 2016

BÜHLMANN GanglioCombi™ MAG ELISA Utilized in Guillain-Barré Syndrome (GBS) and Zika Virus Study

Connect with BUHLMANN Diagnostics Corp at MGCC 2016!

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US